• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I HIV AG/AB COMBO; HIV P24 ANTIGEN AND HIV-1/HIV-2 ANTIBODIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I HIV AG/AB COMBO; HIV P24 ANTIGEN AND HIV-1/HIV-2 ANTIBODIES Back to Search Results
Catalog Number 08P07-77
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/03/2020
Event Type  Injury  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 8p07-77 that has a similar product distributed in the us, list number 8p07-31.
 
Event Description
The customer reported a (b)(6) alinity i hiv ag/ab result on a (b)(6)-yr old female hemodialysis patient with chronic kidney disease stage 5.Results provided: (b)(6) 2020 = (b)(6), architect = (b)(6); elisa and cdc testing were (b)(6).The customer was dialyzed on a designated infectious disease dialysis machine due to the (b)(6) result generated.The patient did not receive any other treatment due to the (b)(6) result.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and inhouse testing of a retained kit of the complaint lot number.Trending review determined no trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot(s) and complaint issue.Inhouse testing determined that the specificity performance of the complaint lot is not negatively impacted.Labelling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency of the alinity i hiv ag/ab combo reagent lot 06105be01 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HIV AG/AB COMBO
Type of Device
HIV P24 ANTIGEN AND HIV-1/HIV-2 ANTIBODIES
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10232509
MDR Text Key198870502
Report Number3002809144-2020-00545
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date04/12/2020
Device Catalogue Number08P07-77
Device Lot Number06105BE01
Was Device Available for Evaluation? No
Date Manufacturer Received07/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE LIST 03R65-01; ALINITY I PROCESSING MODULE LIST 03R65-01; SERIAL (B)(6); SERIAL (B)(6)
Patient Outcome(s) Other;
Patient Age51 YR
-
-